Table 3

Multivariable linear regression analyses of the association of metabolic syndrome with echocardiographic measures of cardiac structure and function in Echo-SOL

	Minimally adjusted beta (SE)	P values	Adjusted beta (SE)	P values
LV mass index, g/m²	2.2 (1.4)	0.11	2.0 (5.7)	0.13
LV end-diastolic volume, mL	1.3 (2.3)	0.58	1.2 (1.9)	0.52
LV end-systolic volume, mL	0.6 (1.0)	0.55	0.6 (0.9)	0.5
LV ejection fraction, %	−0.1 (0.4)	0.78	−0.1 (0.4)	0.88
LV stroke volume, mL	−0.5 (1.4)	0.71	−0.2 (1.3)	0.90
LV longitudinal strain (four chamber), %	−0.2 (0.3)	0.54	−0.3 (0.3)	0.39
LV longitudinal strain (two chamber), %	1.0 (0.4)	0.0196	0.9 (0.3)	0.009
LV global longitudinal strain (average), %	0.5 (0.3)	0.056	0.4 (0.2)	0.07
Medial E′ velocity, cm/s	−0.5 (0.1)	<0.001	−0.4 (0.12)	0.0002
Lateral E′ velocity, cm/s	−0.6 (0.2)	0.016	−0.5 (0.2)	0.02
E/E′	0.5 (0.2)	0.04	0.5 (0.2)	0.01
E/A ratio	−0.07 (0.02)	0.0012	−0.06 (0.02)	0.003
Isovolumic relaxation time, s	0.0007 (0.007)	0.59	0.0005 (0.001)	0.68
Peak RV/RA pressure gradient, mm Hg	−0.6 (0.7)	0.39	−0.7 (0.6)	0.28
TAPSE, cm	0.005 (0.05)	0.92	0.02 (0.04)	0.54
RV fractional area change, %	−0.01 (0.009)	0.12	−0.01 (0.009)	0.20
Left atrial volume index, mL/m²	−0.6 (0.5)	0.28	−0.3 (0.5)	0.53

E/A, mitral inflow E velocity and A velocity ratio; E/E', mitral valve E velocity and E' velocity ratio; Echo-Sol, Echocardiographic Study of Latinos; LV, left ventricle; RA, right atrium; RV, right ventricle; TAPSE, tricuspid annular plane systolic excursion.